ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,783,000 | +90.0% | 168,000 | 0.0% | 4.73% | +84.5% |
| Q1 2019 | $4,096,000 | +71.1% | 168,000 | 0.0% | 2.57% | +13.3% |
| Q4 2018 | $2,394,000 | +23.0% | 168,000 | +31.2% | 2.26% | +80.3% |
| Q3 2018 | $1,946,000 | -9.4% | 128,000 | 0.0% | 1.26% | -14.0% |
| Q2 2018 | $2,148,000 | +17.5% | 128,000 | +14.3% | 1.46% | +21.3% |
| Q1 2018 | $1,828,000 | +614.1% | 112,000 | +460.0% | 1.20% | +702.7% |
| Q4 2017 | $256,000 | – | 20,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |